New drug candidate for Multiple Sclerosis patients

Recently, we identified new drug candidates for multiple sclerosis (MS) patients who do not respond treatment of interferon β (IFNβ), which has been a first-line treatment to MS patients for over 15 years. The study was published in the journal Nature Neuroscience (Inoue et al., 2016; An interferon-β-resistant and NLRP3 inflammasome–independent subtype of EAE with [...]

New drug candidate for Multiple Sclerosis patients 2017-08-10T16:44:38+00:00